» Authors » Guo-Shiou Liao

Guo-Shiou Liao

Explore the profile of Guo-Shiou Liao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 354
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen S, Liao G, Wu C, Cheng M, Shen P, Su Y, et al.
JPRAS Open . 2025 Jan; 43():271-279. PMID: 39811585
Background: Breast cancer patients experience acute radiation dermatitis (ARD) during radiation therapy (RT). This study investigated the prophylactic effect of a newly developed xenogeneic platelet-rich plasma (PRP) lotion on ARD...
2.
Chang Y, Chen Y, Hong Z, Liao G, Yu J
Clin Case Rep . 2024 Dec; 12(12):e9639. PMID: 39677870
Sclerosing adenosis (SA) is a subtype of adenosis characterized by proliferative adenosis and stromal sclerosis with distortion of the terminal ductal lobular unit. Although SA is the most prevalent benign...
3.
Lin T, Chung H, Jian M, Chang C, Perng C, Liao G, et al.
J Med Internet Res . 2024 Sep; 26:e56022. PMID: 39231422
Background: Breast cancer is a leading global health concern, necessitating advancements in recurrence prediction and management. The development of an artificial intelligence (AI)-based clinical decision support system (AI-CDSS) using ChatGPT...
4.
Chang Y, Hong Z, Tsai H, Feng A, Huang T, Yu J, et al.
Breast Cancer . 2024 Aug; 31(6):1114-1129. PMID: 39190284
Background: Breast cancer (BC) is the most common cancer in women and accounts for approximately 15% of all cancer deaths among women globally. The underlying mechanism of BC patients with...
5.
Tseng L, Chen F, Chen S, Cheng F, Chao T, Dai M, et al.
Oncol Res Treat . 2024 Jul; 47(10):484-495. PMID: 39033747
Introduction: This multicenter, phase II randomized, non-inferiority study reports from the first prospective two-armed randomized control trial that compared the efficacy, safety, and quality of life (QoL) of pegylated liposomal...
6.
Chang Y, Hong Z, Yu J, Lin W, Huang T, Tsai H, et al.
Am J Cancer Res . 2023 Dec; 13(11):5719-5732. PMID: 38058819
Gene expression signatures provide valuable information to guide postoperative treatment in breast cancer (BC) patients. However, genetic tests are prohibitively expensive for the majority of BC patients. Immunohistochemical staining (IHC)...
7.
Tsai H, Yu J, Hsu H, Chu C, Chang T, Hong Z, et al.
Nutrients . 2023 Jul; 15(9). PMID: 37432206
Breast cancer is a significant public health problem globally and prevention strategies have become of great interest as its incidence rises. Exploring the connection between dietary patterns and the reduction...
8.
Wang Y, Huang C, Hong Z, Liao G, Yu J
World J Clin Cases . 2023 Mar; 11(7):1521-1527. PMID: 36926394
Background: Invasive breast carcinoma with osteoclast-like stromal giant cells (OGCs) is an extremely rare morphology of breast carcinomas. To the best of our knowledge, the most recent case report describing...
9.
Liu F, Chang S, Hsu K, Chen Y, Pan H, Liao G, et al.
Obes Surg . 2023 Mar; 33(5):1616-1619. PMID: 36856990
Background: Bariatric surgery has actually focused not only on obesity but also more on the improvements or remission of the metabolic diseases. Therefore, revisional surgery is indicated for patients with...
10.
Hsu K, Chang S, Lee W, Ser K, Pan H, Chen Y, et al.
Obes Surg . 2023 Feb; 33(4):1318-1322. PMID: 36810810
Background: Bariatric surgery has been proven to be the most effective treatment for obesity with or without metabolic syndrome. One anastomosis gastric bypass (OAGB) is a well-established bariatric procedure developed...